GAIN THERAPEUTICS, INC (GANX)

Import this data to Google Sheets with:

=jivedata("GANX","financials")

Full statements spill as a table. For one cell: =jivedata("GANX","Revenue") or =jivedata("GANX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

GAIN THERAPEUTICS, INC

GANX • CIK 0001819411

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$11,520.613	$10,791.058	$10,212.782	$10,098.343
General and Administrative Expense	$10,787.7	$9,559.534	$8,497.92	$9,188.654
Operating Income (Loss)	$-22,253.133	$-20,350.592	$-18,710.702	$-19,286.997
Operating Expenses	$22,308.313	$20,350.592	$18,710.702	$19,286.997
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-22,188.245	$-19,874.376	$-19,299.981	$-19,199.717
Income Tax Expense (Benefit)	$79.275	$536.815	$861.118	$906.54
Net Income (Loss) Attributable to Parent	$-22,267.52	$-20,411.191	$-20,161.099	$-20,106.257
Interest Income (Expense), Nonoperating, Net	—	$357.096	$244.394	$315.527
Foreign Currency Transaction Gain (Loss), before Tax	$-429.346	$119.12	$-833.673	$-228.247
Weighted Average Number of Shares Outstanding, Basic	13,011,361	22,881,415	32,968,336	46,006,979

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$11,794.949	$10,385.863	$20,837.628	$13,084.144
Deferred Income Taxes and Other Tax Receivable, Current	$242.577	$271.079	$179.701	$210.494
Prepaid Expense and Other Assets, Current	$741.638	$945.536	$1,219.809	$1,675.11
Assets	$18,609.331	$12,123.884	$22,818.975	$15,421.939
Assets, Current	$17,778.868	$11,602.478	$22,237.138	$14,969.748
Property, Plant and Equipment, Net	$125.962	$103.619	$74.916	$47.026
Capitalized Computer Software, Net	$193.375	$134.268	$102.837	$76.782
Operating Lease, Right-of-Use Asset	$459.215	$219.715	$334.09	$266.861
Restricted Cash, Noncurrent	$34.021	$31.695	$36.296	$35.589
Assets, Noncurrent	$830.463	$521.406	$581.837	$452.191
Liabilities	$6,031.107	$4,784.31	$4,254.227	$4,129.908
Common Stock, Value, Issued	$1.621	$2.713	$4.209	$4.335
Additional Paid in Capital	$73,113.079	$88,779.318	$119,139.677	$121,924.254
Accumulated Other Comprehensive Income (Loss), Net of Tax	$247.241	$-247.549	$776.869	$1,003.752
Retained Earnings (Accumulated Deficit)	$-38,516.197	$-60,783.717	$-81,194.908	$-111,640.31
Stockholders' Equity Attributable to Parent	$12,578.224	$7,339.574	$18,564.748	$11,292.031
Accounts Payable, Current	$1,318.965	$946.259	$825.027	$1,220.365
Operating Lease, Liability, Current	$229.693	$160.913	$119.876	$109.428
Other Liabilities, Current	$2,160.366	$2,441.761	$2,306.624	$1,980.444
Deferred Income, Current	$1,122.138	$252.211	$252.211	$11.293
Long-term Debt, Current Maturities	$118.797	$110.177	$100.869	$123.628
Liabilities, Current	$4,949.959	$3,911.321	$3,352.396	$3,433.865
Liability, Defined Benefit Pension Plan, Noncurrent	$307.454	$443.623	$390.509	$319.225
Operating Lease, Liability, Noncurrent	$229.855	$53.598	$211.238	$156.76
Deferred Income, Noncurrent	$94.786	$47.441	$47.441	$47.441
Long-term Debt, Excluding Current Maturities	$449.053	$328.327	$300.084	$220.058
Liabilities, Noncurrent	$1,081.148	$872.989	$901.831	$696.043
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	50,000,000	50,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	16,206,680	27,132,588	42,073,807	43,340,501

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-22,267.52	$-20,411.191	$-20,161.099	$-20,106.257
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$488.404	$-527.168	$474.032	$-12.615
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$4,486.541	$-1,411.412	$10,456.366	$6,389.319
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$11,828.97	$10,417.558	$20,873.924	$28,346.587
Depreciation, Depletion and Amortization	$83.579	$84.071	$94.046	$99.531
Payments to Acquire Productive Assets	$15.358	$22.493	$22.493	$22.493
Share-based Payment Arrangement, Noncash Expense	$3,259.026	$2,390.159	$1,803.195	$1,831.231
Proceeds from Sale and Maturity of Marketable Securities	—	$5,000	$5,000	$5,000
Other Noncash Income (Expense)	$383.188	$-143.523	$-804.938	$-352.434
Net Cash Provided by (Used in) Investing Activities	$10,222.667	$4,977.507	$4,977.507	$4,977.507
Proceeds from Warrant Exercises	—	$113.8	$3,218.552	$3,218.552
Proceeds from Stock Options Exercised	—	$57.711	$250.26	$250.26
Payments of Stock Issuance Costs	$900	$280.867	$395.478	$395.478
Repayments of Short-term Debt	$89.067	$90.879	$96.501	$100.843
Net Cash Provided by (Used in) Financing Activities	$12,641.343	$13,012.076	$28,447.766	$25,354.389
Income Taxes Paid, Net	$134.962	$86.309	$47.549	$47.549
Increase (Decrease) in Prepaid Expense and Other Assets	$-184.446	$356.65	$82.119	$-677.5
Increase (Decrease) in Other Noncurrent Assets	$10.057	$21	$-2.852	$-10.927
Increase (Decrease) in Accounts Payable and Accrued Liabilities	—	$274.889	$-468.606	$-1,687.734
Increase (Decrease) in Obligation, Pension Benefits	—	$-122.915	$-130.568	$-119.45
Increase (Decrease) in Deferred Liabilities	$1,085.294	$-854.713	$-328.071	$-10.637
Increase (Decrease) in Operating Capital	$-442.23	$1,080.389	$1,006.512	$1,129.394
Net Cash Provided by (Used in) Operating Activities	$-18,865.873	$-18,873.827	$-18,465.432	$-18,952.455

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("GANX","financials")

Full statements spill as a table. For one cell: =jivedata("GANX","Revenue") or =jivedata("GANX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.